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Introduction
Actin-binding Kelch-like ECH-associated protein 1 (Keap1) 
and a leucine zipper motif-containing transcription factor 
nuclear factor erythroid 2-related factor 2 (Nrf2) form a pathway 
combating a variety of xenobiotic and endobiotic insults.1 In the 
quiescent state, cytosolic Keap1, as an adaptor, tethers Nrf2 for 
ubiquitin conjugation by a Cul3-containing E3 ubiquitin ligase, 
targeting Nrf2 for proteasomal degradation. When oxidative 
stress occurs, Keap1, as a redox sensor, undergoes a conforma-
tional change because of the modification of its ultra-sensitive 
cysteine residues by oxidative stress-causing highly active mol-
ecules such as electrophiles. As a result, Nrf2 escapes from ubiq-
uitin conjugation, translocates into the nucleus, and, in turn, 
transcriptionally activates a group of genes encoding cytoprotec-
tive molecules, including detoxifying enzymes, GSH synthesis 
enzymes, and antioxidant proteins.2 These molecules coordi-
nately combat oxidative stress, thus restoring cellular homeosta-
sis. Subsequently, Keap1 translocates into the nucleus and escorts 
nuclear export of Nrf2 for continuous proteasomal degradation 
in the cytoplasm, thus terminating Nrf2 activation.3,4 Moreover, 
Keap1 can interact with other proteins and Nrf2 activity can be 
regulated by Keap1-independent mechanisms,5-7 indicating their 
independent regulation and roles in different biological or patho-
logical processes.
It has been shown that Nrf2 deficiency causes impairment 
of liver regeneration due to oxidative stress-mediated insulin/
insulin-like growth factor resistance and diminished Notch1 sig-
naling.8,9 The aim of our study was to gain further insights into 
the roles of the Keap1/Nrf2 signaling pathway in regulating liver 
regeneration, with a particular focus on determining whether and 
how Keap1 modulates the cell cycle of regenerating hepatocytes. 
Two-thirds partial hepatectomy (PH) was used in our study 
because PH induces highly synchronized cell cycle progression in 
hepatocytes without inflicting major cellular injury and inflam-
mation.10-12 In mice, after PH, mature hepatocytes display 4 con-
secutive waves of replication, eventually restoring the lost liver 
mass in 7 to 10 d. During the first and strongest wave of hepatic 
proliferative cycle, hepatocytes reach the G
1
/S boundary around 
24 h, undergo DNA synthesis (S phase) with a peak at 36 h, 
and, in turn, exhibit a mitosis peak (M phase) at Zeitgeber time 
0 on the second day, following PH.10,13,14 This well-characterized 
in vivo process enabled us to precisely evaluate the regulatory 
role of the Keap1/Nrf2 pathway at each stage of the cell cycle. 
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Keap1 negatively controls the activity of transcription factor Nrf2. this Keap1/Nrf2 pathway plays a critical role 
in combating oxidative stress. We aimed at determining whether and how Keap1 modulates the cell cycle of replicat-
ing hepatocytes during liver regeneration. two-thirds partial hepatectomy (pH) was performed on wild-type mice and 
Keap1+/− (Keap1 knockdown) mice. We found that, following pH, Keap1 knockdown resulted in a delay in S-phase entry, 
disruption of S-phase progression, and loss of mitotic rhythm of replicating hepatocytes. these events are associated with 
dysregulation of c-Met, eGFR, Akt1, p70S6K, Cyclin A2, and Cyclin B1 in regenerating livers. Astonishingly, normal regener-
ating livers exhibited the redox fluctuation coupled with hepatocyte cell cycle progression, while keeping Nrf2 quiescent. 
Keap1 knockdown caused severe disruption in both the redox cycle and the cell cycle of replicating hepatocytes. thus, we 
demonstrate that Keap1 is a potent regulator of hepatic redox cycle and hepatocyte cell cycle during liver regeneration.
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In addition, studies using cultured mammalian cells or yeast 
demonstrate that the cell cycle is coupled with the redox cycle.15 
However, this has not been confirmed in vivo in mammals. Thus, 
we also aimed at determining whether the redox cycle is inte-
grated into hepatocyte cell cycle and is regulated by the Keap1/
Nrf2 pathway during liver regeneration. Because the Keap1-null 
mutation causes postnatal lethality,16 Keap1+/− mice were cho-
sen for our study to evaluate the effects of Keap-1 knockdown 
on hepatocyte proliferation. We performed PH on wild-type and 
Keap1+/− mice and performed various analyses at multiple time 
points after surgery. We found that regenerating livers exhibited 
high magnitudes of redox fluctuation as replicating hepatocytes 
progressed through the cell cycle and Keap1 knockdown elicited 
potent effects on hepatic redox cycle and the cell cycle of replicat-
ing hepatocytes during liver regeneration.
Results
Keap1 knockdown does not significantly affect liver 
regrowth after PH
In the quiescent state, the average liver-to-body weight ratio 
in Keap1+/− mice is slightly lower than that in their wild-type 
littermates (4.62% ± 0.16 vs. 5.22% ± 0.18; P < 0.05, n = 5), 
indicating that Keap1+/− mice have a reduced liver size. Using 
the liver-to-body weight ratio as a liver regrowth parameter, 
we found that Keap1 knockdown did not significantly impact 
liver regrowth and final hepatic mass restoration following PH 
(Fig. S1).
Keap1 knockdown causes a delay in S phase entry, aberrant 
S phase progression, and loss of mitotic rhythm of replicating 
hepatocytes following PH
By counting Ki67-positive hepatocytes, we observed that 
Keap1+/− mice displayed marked alterations in the numbers of 
cycling hepatocytes during the first wave of hepatic proliferative 
cycle (24 h to 60 h after PH) in comparison with their wild-
type controls (Fig. 1A; Fig. S2). By quantifying BrdU-positive 
(S-phase) hepatocytes, we found that Keap1 knockdown caused 
a delay in S phase entry and subsequent disruption in S phase 
progression during the first round of hepatocyte cell cycle follow-
ing PH (Fig. 1B; Fig. S3). We also quantified hepatocyte mitotic 
figures representing M-phase hepatocytes (Fig. 1C). After PH, 
Keap1+/+ mice displayed 4 waves of hepatocyte mitosis rhythmi-
cally as anticipated, whereas the hepatocyte mitotic rhythm was 
lost in Keap1+/− mice.
Nrf2 is not activated during the first hepatic proliferative 
cycle after PH in wild-type mice
To evaluate the functional state of the Keap1/Nrf2 signal-
ing pathway, we analyzed hepatic protein expression of Keap1 
and mRNA expression of Nrf2 and its target genes during the 
first round of hepatocyte cell cycle after PH (Fig. 2). Nrf2 activ-
ity is regulated at multiple levels, including gene transcription, 
Keap1-dependent and -independent proteasome degradation, 
kinase-mediated phosphorylation, cytoplasm-nucleus traffick-
ing, and DNA binding.17,18 However, the endpoint for assessing 
Nrf2 activity is the mRNA levels of Nrf2 target genes. NAD(P)
H:quinone oxidoreductase 1 (NQO1), glutathione peroxidase 
2 (GPX2), and glutathione S-transferase mu 3 (GSTmu3) are 
typical direct target genes of Nrf2.19,20 Even during liver injury, 
NQO1 is solely regulated by Nrf2.21 Thus, the mRNA levels 
of these genes allowed us to reliably monitor Nrf2 activity. As 
expected, in comparison with pre-PH Keap1+/+ mice, pre-PH 
Keap1+/− mice displayed a decrease in hepatic Keap1 protein 
expression and increases in the levels of hepatic NQO1, GPX2, 
and GSTmu3 transcripts, indicating Keap1 knockdown effects. 
This observation is in line with a report.22 In wild-type mice, 
compared with pre-PH livers, regenerating livers exhibited 
dynamic alterations in Keap1 protein expression, constant Nrf2 
transcript levels, and not significantly changed expression of 
NQO1, GPX2, and GSTmu3 genes. The data demonstrate that, 
in wild-type mice subjected to PH, hepatic Nrf2 is not activated 
and it needs to be kept quiescent and stable when hepatocytes 
enter and progress through the cell cycle. Moreover, in compari-
son with wild-type regenerating livers, Keap1+/− regenerating 
livers expressed less Keap1 protein, equivalent Nrf2 transcripts, 
and initially (prior to 36 h after PH) unchanged but subsequently 
(at 36 h post-PH and thereafter) elevated levels of NQO1, GPX2, 
and GSTmu3 mRNAs. Thus, Keap1 knockdown resulted in dys-
regulation of Nrf2 activity during liver regeneration. Kruppel-
like factor 9 (Klf9) was recently identified as a Nrf2 target gene 
by Nikiforov’s group. They demonstrated that when intracellu-
lar ROS level elevates above a critical threshold, Nrf2 stimulates 
Klf9 expression, leading to amplification of oxidative stress and 
thereby cell death.23 We found that hepatic Klf9 expression did 
not exhibit significant PH-dependent changes in Keap1+/+ mice 
and there was no significant differences in Klf9 mRNA levels 
between Keap1+/+ and Keap1+/− mice after PH. The data sug-
gest that although hepatic Nrf2 was activated after 36 h post-PH 
due to Keap1 knockdown, Nrf2 activity did not surpass a thresh-
old leading to Klf9 upregulation.
Keap1 knockdown leads to dysregulation of a subset of cell 
cycle components during liver regeneration
Keap1 knockdown resulted in altered protein expression of 
hepatic Cyclins D1, A2, E1, and B1 following PH (Fig. 3). Most 
notably, before 44 h post-PH, the dysregulation of Cyclin A2 pro-
tein expression was closely correlated with the disruption of the 
S phase progression in Keap1+/− regenerating livers (Fig. 1B). 
At 44 h after PH and thereafter, Keap1+/− regenerating livers 
accumulated excessive Cyclin A2 protein relative to wild-type 
controls. In addition, after 48 h post-PH, Keap1 knockdown led 
to prevention of hepatic Cylin B1 protein expression, which was 
associated with the loss of mitotic rhythm of cycling hepatocytes 
(Fig. 1C). Together, the results demonstrate that Keap1 knock-
down causes dysregulation of a subset of cell cycle components, 
especially Cyclins A2 and B1, during liver regeneration.
Keap1 knockdown results in dysregulation of several mito-
genic signaling molecules in regenerating livers
Hepatocyte growth factor (HGF) and epidermal growth fac-
tor (EGF) are 2 of the most potent direct mitogens for hepa-
tocytes and act via their receptors c-Met and EGF receptor 
(EGFR), respectively.24 We found that Keap1 knockdown led to 
the inhibition of hepatic c-Met phosphorylation throughout the 
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liver regrowth process, most strikingly at 30 h after PH (Fig. 4). 
In addition, Keap1 knockdown also suppressed hepatic EGFR 
phosphorylation in the resting state and prior to 44 h post-PH 
(Fig. 4). Evidence supports the role of Akt/mTOR signaling 
in controlling the cell cycle progression of proliferative hepato-
cytes.25 As shown in Figure 3, Keap1 knockdown disrupted the 
phosphorylation patterns of hepatic Akt1 at both S473 and T308 
and those of p70S6K at both T389 and S371 after PH. Of note, 
p70S6K phosphorylation at T389 was approximately 
synchronized with Akt1 phosphorylation at T308, 
rather than with its known upstream direct regulator 
mTOR, in both genotypes of mice during the entire 
course of liver regrowth. This observation strongly 
suggests that Akt1 and p70S6K directly form a sig-
naling pathway during liver regeneration. Notably, 
in Keap1+/− mice, at 30 h after PH, the S phase 
entry delays of replicating hepatocytes (Fig. 1B) were 
accompanied by inactivation of hepatic Akt1 (T308) 
and p70S6K (T389). Collectively, we linked Keap1 
to the 4 mitogenic signaling molecules (c-Met, 
EGFR, Akt1, and p70S6K) in regenerating livers.
Keap1 knockdown causes disruption in hepatic 
redox regulation in regenerating livers
Cell proliferation is tightly coupled with cellu-
lar redox homeostasis systems.15 The involvement 
of the Keap1/Nrf2 signaling system in regulating 
cellular redox balance prompted us to evaluate the 
redox states by dihydroethidium (DHE) staining 
and thiobarbituric acid reactive substances (TBARS) 
measurement during the first wave of hepatocyte 
proliferation (Fig. 5). Astonishingly, at 24 h post-PH 
(G
1
/S boundary), regenerating livers were in a highly 
oxidative state. Subsequently, wild-type regenerating livers con-
verted to a reductive state at 30 h post-PH, underwent mildly 
increased oxidative stress at 34 h, returned to a reductive state at 
36 h, and then exhibited more mildly increased oxidative stress 
at 40 h. The 3 waves of redox fluctuation were conversely rel-
evant with the changes in DNA synthesis activity in wild-type 
regenerating livers (Fig. 1B). Clearly, when the level of oxidative 
stress was high, DNA synthesis activity was low, and vice versa. 
Figure 1. (A) Assessment of total proliferating hepatocytes. 
Wild-type (Keap1+/+) and Keap1 knockdown (Keap1+/−) 
mice were subjected to partial hepatectomy (pH) and sac-
rificed at the indicated time points. Ki-67 immunostaining 
was performed with liver sections. Ki67-positive hepato-
cytes were counted at 200x magnification in 5 randomly 
chosen fields per section. the results are shown as the 
means per field ± SD (n = 3–8 mice per genotype per time 
point). Asterisks represent P < 0.05 in comparison between 
Keap1+/+ and Keap1+/− mice. (B) Assessment of S-phase 
hepatocytes during the first round of hepatocyte cell cycle 
post-pH. one hour prior to sacrifice, BrdU was injected into 
the mice (100 mg/kg, i.p.). Liver sections were subjected 
to BrdU immunostaining. BrdU-positive hepatocytes were 
counted at 200x magnification in 5 randomly chosen fields 
per section. the data are shown as the means per field ± 
SD (n = 3–8 mice per genotype per time point). Asterisks 
represent P < 0.05 in comparison between Keap1+/+ and 
Keap1+/− mice. (C) Assessment of M-phase hepatocytes. 
After pH, mice were sacrificed at the indicated time points. 
Liver sections were stained with hematoxylin and eosin. 
Hepatocyte mitotic figures indicative of hepatocytes 
undergoing mitosis were counted at 100x magnification 
in 5 randomly chosen fields per liver section. the data 
are shown as the means per field ± SD (n = 3–8 mice per 
genotype per time point). Asterisks represent P < 0.05 in 
comparison between the time points indicated in each 
genotype group of mice.
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These findings demonstrate that normal regenerating livers 
exhibit strong redox fluctuation, which is coupled with the cell 
cycle progression of proliferating hepatocytes. Strikingly, Keap1 
knockdown elicited a severe destructive effect on hepatic redox 
regulation, closely correlating with the disruption of hepatocyte 
S phase progression (Fig. 1B). Thus, our data demonstrate that 
regenerating livers exhibit the redox cycle and Keap1 is a power-
ful redox cycle modulator.
Keap1 knockdown results in an increase in hepatocyte 
genome integrity and stability in regenerating livers
To address a concern as to whether the genome integrity and 
stability can be maintained in Keap1+/− regenerating hepato-
cytes exposed to an abnormal redox environment, we assessed 
DNA damage by quantifying the foci of phosphorylated histone 
H2AX (γ-H2AX) in hepatocytes (Figs. 6A and B). H2AX is 
activated (phosphorylated) in response to DNA damage and par-
ticipates in assembling repair proteins at damaged sites. It is used 
as a sensitive marker to detect DNA damage in cells, including 
hepatocytes.26 We found that most hepatocytes in pre-PH livers 
exhibited 2–4 γ-H2AX+ foci per nucleus. In wild-type regenerat-
ing livers, the number of nuclei displaying more than 4 γ-H2AX+ 
foci in S-phase hepatocytes increased most markedly at 36 h 
post-PH (DNA synthesis peak), accompanied by peak expres-
sion of DNA repair genes RAD51and RAD51-like 1(RAD51l1) 
(Fig. 6C). In contrast, in Keap1+/− regenerating livers, the 
spontaneous replication-induced DNA damage was completely 
prevented even at 34 h after PH when DNA synthesis peaked 
(Fig. 1B), and this effect was accompanied by higher expression of 
hepatic RAD51 and RAD51l1 than wild-type controls 
at this time point (Fig. 6C). These data demonstrate 
that Keap1 knockdown results in improved hepatocyte 
genome integrity and stability during hepatocyte DNA 
replication, which is associated with increased expres-
sion of the DNA repair genes RAD51 and RAD51l1.
Discussion
The current study identified Keap1 as a potent regu-
lator of the cell cycle of proliferating hepatocytes during 
liver regeneration. A reduction in Keap1 expression as a 
result of the loss of one Keap1 allele results in a delay 
in S phase entry, disruption of S phase progression, and 
loss of the mitotic rhythm of replicating hepatocytes 
during hepatic regrowth following PH. Thus, an appro-
priate level of Keap1 expression is essential for hepato-
cytes to progress through the cell cycle in an innate 
way. On the other hand, Keap1 knockdown leads to 
increased genome integrity and stability when hepato-
cytes undergo massive DNA replication in response to 
liver mass decrease. This may explain, at least in part, 
why Keap1+/− mice did not exhibit an overt defect in 
overall hepatic regrowth after PH, despite the disrup-
tion in the hepatocyte cell cycle.
Mechanistically, we linked Keap1 to several mito-
genic signaling molecules (c-Met, EGFR, Akt1, and 
p70S6K) and Cyclins A2 and B1. It has been demon-
strated that S phase entry is severely suppressed in hepa-
tocytes deficient in c-Met, EGFR, or p70S6K, thereby 
delaying liver regeneration.25,27,28 However, how Keap1 
regulates these signaling molecules remains an open 
question. To the best of our knowledge, we for the first 
time linked Keap1 to c-Met activity. In non-small-cell 
lung cancer cells, Keap1 knockdown reduces the sen-
sitivity to EGFR-tyrosine kinase inhibitors and EGFR 
phosphorylation activates Nrf2, indicating a cross talk 
between EGFR and Keap1/Nrf2 signaling pathway.29 
It is unclear whether this cross talk also operates in 
hepatocytes.
Figure 2. (A) Hepatic expression of Keap1 protein during the first wave of hepato-
cyte proliferation after partial hepatectomy (pH) in Keap1+/+ and Keap1+/− mice. 
total liver lysates were prepared from the livers collected at the indicated time 
points after pH. Western blotting was performed with an antibody against Keap1 
protein. Glyceraldehyde 3-phosphate dehydrogenase (GADpH) was used as a load-
ing control. A representative blot of 3 independent experiments is shown. NL, 
normal liver. (B) Hepatic mRNA expression of Nrf2, NQo1, GpX2, GStmu3, and Klf9 
during the first wave of hepatocyte proliferation after pH in Keap1+/+ and Keap1+/− 
mice. total RNA was prepared from liver tissues collected prior to or after pH at the 
indicated time points. Hepatic mRNA levels for the genes indicated were measured 
by qRt-pCR and are expressed as the mean fold changes compared with wild-type 
normal controls ± SD (n = 3 mice per time point per genotype). Asterisks represent 
P < 0.05 in comparison between Keap1+/+ and Keap1+/− mice.
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In the cell cycle of mammalian cells, Cyclin A2 drives the S 
phase progression together with Cdk2 and the initiation of chro-
mosome condensation by associating with Cdc2.30-33 Thus, it is 
highly likely that Cyclin A2 is the major effector underlying the 
mitogenic signaling and eventually affecting the S phase entry 
and DNA synthesis in proliferating hepatocytes. It is known 
that the activity of the Cdc2/Cyclin B complex is essential for 
M phase entry in mammalian cells34 and this pathway regulates 
the timing of hepatocyte mitosis during liver regeneration.13 
Moreover, timely degradation of Cyclin A is required for M phase 
progression.35,36 Therefore, the absence of Cyclin B1 expression 
and the excessive amount of Cyclin A2 contribute to the loss of 
the mitotic rhythm after 44 h post-PH in Keap1+/− regenerating 
livers.
A variety of studies using cultured mammalian cells or yeast 
demonstrate that proliferating cells progress through the cell cycle 
in a manner synchronized with the redox cycle. The G
1
 phase 
advances in the oxidative state, whereas the S phase and M phase 
are completed only in the reductive state to ensure the fidelity of 
replicated DNA.15 To the best of our knowledge, this finding has 
not been confirmed in vivo in mammals. We discovered for the 
first time the 3 waves of hepatic redox fluctuation and their cou-
pling with hepatocyte cell cycle progression in regenerating livers. 
It is astonishing to observe a striking surge of hepatic free radi-
cals at the G
1
/S boundary (24 h post-PH), followed by 2 addi-
tional progressively reduced surges in the S phase, of proliferating 
hepatocytes during liver regeneration in wild-type mice (Fig. 5). 
We believe that such unusual redox fluctuation is well tolerated, 
tightly controlled, and indispensably required by regenerating 
livers. It is intriguing how regenerating livers produce such a large 
amount of free radicals. It is our great future interest to investi-
gate the biological significance of this phenomenon. Excessive 
ROS are deleterious because they damage macromolecules, but 
increasing evidence supports 
the role of ROS as signal-
ing molecules.15,37,38 A high 
ROS level is necessary for 
the activation of the mito-
genic signaling pathways 
that drive the transcrip-
tion of cyclin genes.37 ROS 
transduce molecular signal-
ing by oxidizing the cysteine 
residues of a number of cell 
cycle regulators and compo-
nents in mitogenic signaling 
cascades. Cysteine oxidation 
may be as important as phos-
phorylation in signal trans-
duction.15 However, excessive 
ROS are deleterious because 
they damage macromol-
ecules. For example, reactive 
aldehydes such as malondial-
dehyde and 4-hydroxynon-
enal, the end products of 
ROS-induced lipid peroxidation, damage the cell membrane and 
even cause DNA mutagenesis and carcinogenesis.39 Thus, there 
must be a potent mechanism quickly terminating ROS produc-
tion and thereby lipid peroxidation to avoid detrimental effects of 
a high level of oxidative stress. It is intriguing how regenerating 
livers produce such a large amount of free radicals and quickly 
neutralize them. It is our great future interest to investigate the 
biological significance of this phenomenon. Our findings dem-
onstrate that PH is an ideal in vivo model to study the redox 
biology.
The current study also identified Keap1 as a powerful redox 
modulator. Completely unexpected and contrary to the well-
established function of the Keap1/Nrf2 signaling pathway in 
combating oxidative stress, Nrf2 is not activated while the 3 
waves of the redox fluctuation occur in wild-type regenerating 
livers (Fig. 2). This observation indicates that Nrf2 needs to be 
kept quiescent when replicating hepatocytes progress through 
the cell cycle. Apparently, in wild-type mice, elevation of hepatic 
Keap1 protein expression at 24, 34, and 44 h after PH in response 
to ROS surge at those time points should prevent Nrf2 from 
activation (Figs. 2A and 5). Keap1 knockdown causes multiple 
detrimental effects including dysregulation in Nrf2 activity, 
cyclin expression, mitogenic signaling, and the redox cycling, 
causing disruption of the cell cycle progression of proliferating 
hepatocytes. A recent report shows that a constitutively active 
Nrf2 mutant in hepatocytes does not exhibit any overt benefi-
cial effects on chronic liver injury and impairs PH-induced liver 
regeneration by delaying hepatocyte proliferation and enhancing 
hepatocyte apoptosis.40 This report and our finding support a 
notion that proliferating hepatocytes require prohibition of Nrf2 
activation to normally progress through the cell cycle during liver 
regeneration. Intriguingly, prior to 36 h after PH, hepatic Nrf2 
activity did not differ between Keap1+/+ and Keap1+/− mice 
Figure 3. protein expression of a subset of cell cycle components in regenerating livers of Keap1+/+ and Keap1+/− 
mice. Livers were collected from normal mice and the mice subjected to partial hepatectomy (pH) at the indi-
cated time points after surgery. Western blotting was performed using liver lysates pooled from 3 mice per time 
point per genotype with antibodies against the proteins indicated. Glyceraldehyde 3-phosphate dehydrogenase 
(GADpH) was used as a loading control. NL, normal liver.
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(Fig. 2B), while hepatic Cyclin A2, several mitogenic signaling 
molecules, and the redox fluctuation exhibited dysregulation due 
to Keap1 knockdown (Figs. 3, 4, and 5). These observations 
strongly suggest an additional Nrf2-independent mechanism 
behind these Keap1-depedent events. Although Nrf2 is the best 
characterized and primary Keap1 substrate, other Keap1 sub-
strates or interacting proteins have been found, at least includ-
ing IKKβ, Bcl-2/Bcl-xL, p62/sequestosome-1, and p21.41 Thus, 
it warrants future studies to elucidate how Keap1 exerts regula-
tory effects in addition to Nrf2-mediated pathway during liver 
regeneration. Moreover, we observed that, in Keap1+/− regen-
erating livers, Nrf2 target genes were upregulated at later stage 
during the first round of hepatocyte cell cycle, although Keap1 
protein levels were reduced throughout this period (Fig. 2). 
Nrf2 activity is modulated by multiple mechanisms, including 
transcriptional regulation of Nrf2 gene, miRNA species-medi-
ated control of Nrf2 mRNA, Keap1-mediated Nrf2 proteasome 
degradation, competition for binding to Keap1, ubiquitin ligase 
Hrd1-mediated Nrf2 ubiquitylation, kinase-induced posttrans-
lational modification of Nrf2, and competition for binding to 
ARE.17,42 These mechanisms may operate dynamically to regu-
late Nrf2 activity during liver regeneration. When Keap1 was 
knocked down, Nrf2 exhibited quiescence initially but activation 
later during the first wave of hepatocyte replication after PH. The 
observation suggests that Keap1 may play a dominant role in the 
regulatory machinery at later stage of hepatocyte cell cycle.
Of note, Keap1+/− mice used in this study represent a mouse 
model with Keap1 knockdown globally in all cell types includ-
ing parenchymal and non-parenchymal cells in the liver. Liver 
regeneration is a highly orchestrated process which is regulated 
by numerous factors generated intra- and/or extra-hepatically. 
Thus, global Keap1 knockdown-induced systemic effects and 
local effects in non-parenchymal cells in the liver may contribute 
to Keap1-depedent phenotypes during liver regeneration. Further 
studies using hepatocyte-
specific Keap1 knockdown 
or knockout mice will not 
only confirm the findings 
described in this report but 
also allow us to precisely 
evaluate the function of 
Keap1 in hepatocytes after 
liver resection. It has been 
shown that hepatocyte-
specific deletion of Keap1 
gene leads to chronic acti-
vation of Nrf2 and thereby 
resistance to xenobiotics 
without overt influence on 
morphological and physi-
ological integrity of hepato-
cytes.43 Therefore, it should 
be an ideal mouse model to 
further investigate the role 
of Keap1 in regulating the 
redox cycle and hepatocyte 
cell cycle in response to 
liver mass loss.
In summary, we dem-
onstrate that proliferat-
ing hepatocytes require 
precisely regulated Keap1 
expression to enter and 
progress through the S 
phase and exhibit mitotic 
rhythm during liver regen-
eration. An appropriate 
level of Keap1 expression is 
essential for proper regula-
tion of the redox cycle, the 
activities of c-Met, EGFR, 
Akt1, and p70S6K, and the 
expression of Cyclins A2 
Figure 4. protein expression of a subset of mitogenic signaling molecules in regenerating livers of Keap1+/+ and 
Keap1+/− mice. Liver lysates were prepared as described in Figure 3. Western blotting was performed with anti-
bodies against the proteins indicated. GADpH was used as a loading control. Blue and red boxes indicate the simi-
lar phosphorylation patterns of p-Akt1 (t308) and p-p70S6K (t389) in Keap1+/+ and Keap1+/− regenerating livers, 
respectively.
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and B1 in regenerating livers. Keap1 plays these regulatory roles 
possibly through both Nrf2-depedent and -independent mecha-
nisms. Further studies are needed to integrate the Keap1 signal-
ing, redox signaling, mitogenic signaling, and cyclin expression 
into the machinery governing the hepatocyte cell cycle during 
liver regeneration (Fig. 7).
Materials and Methods
Mice and PH
The mice were housed in plastic cages at 22 ± 1 °C on a 12-h 
light/12-h dark cycle with lights on from 6:00 AM to 6:00 
PM Standard rodent chow and water were provided ad libitum 
throughout the entire feeding period. Keap1+/− mice with a 
mixed genetic background of C57BL6/129Sv were purchased 
from RIKEN BioResource Center of Japan (RBRC01388).16 
Wild-type and Keap1+/− male mice (5 to 6-mo-old) were used 
for the study. Standard PH was performed 
following a previously described proce-
dure.44 The gall bladders were kept intact. 
The surgery was performed between 10:00 
AM and 12:00 PM All of the animal 
experiments were conducted in accordance 
with the National Institutes of Health 
Guide for the Care and Use of Laboratory 
Animals. The protocols for the care and use 
of animals were approved by the Indiana 
University-Purdue University Indianapolis 
Animal Care and Use Committee.
Hepatocyte proliferation assessments
One hour before animal sacrifice, 
5-bromo-2-deoxyuridine (BrdU) was 
injected into the mice (100 mg/kg, i.p.). 
Formalin-fixed and paraffin-embedded 
liver sections were subjected to K
i
-67 or 
BrdU immunostaining to visualize and 
count the proliferating hepatocytes or were 
stained with hematoxylin and eosin to 
quantify the mitotic figures in hepatocytes. 
Ki67-postive (200×) or BrdU-positive 
(200×) hepatocytes and hepatocyte mitotic 
Figures (100×) were counted in 5 randomly 
chosen microscope fields per section. 
Primary antibodies against K
i
-67 (Thermo 
Scientific) or BrdU (#5292, Cell Signaling 
Technology) were used for immunos-
taining according to the manufacturer’s 
instructions.
Western blot analysis
Liver homogenates (10 or 30 µg) were 
separated by PAGE under reducing con-
ditions. Proteins were electrophoretically 
transferred from the gels to polyvinylidene 
difluoride membranes. Antibodies against 
Cyclin D1 (#2922), Cyclin B1 (#4138), 
p-p70S6K (T389) (#9234), p-p70S6K (S371) (#9208), p70S6K 
(#2708), p-4E-BP1 (T37/46) (#2855), 4E-BP1 (#9644), mTOR 
(#2983), and p-MTOR (S2448) (#5536) (Cell Signaling 
Technology); against Cyclin A2 (1540–1), Akt1 (#1081–1), 
p-Akt1 (T308) (#2214–1), p-Akt1 (S473) (#2118–1), epider-
mal growth factor (EGFR) (#1114–1), and p-EGFR (Y1086) 
(Epitomics); against c-Met (#47431) and p-c-Met (#5662) 
(Abcam, Cambridge, MA); and against Cyclin E1 (SC-481), 
glyceraldehyde 3-phosphate dehydrogenase (GADPH) (SC-
25778), and Keap1 (SC-33569) (Santa Cruz Biotechnology) 
were used as probes. Immune complexes were detected using an 
enhanced chemiluminescence system (Pierce).
Quantitative real-time polymerase chain reaction 
(qRT-PCR)
Total RNA was isolated from frozen liver tissue using TRIzol 
reagent according to the manufacturer’s protocol (Invitrogen). 
cDNAs were synthesized from the total RNA (1 µg) of each 
sample using a Verso cDNA Kit (Thermo Scientific), diluted 4 
Figure 5. Hepatic redox states during the first wave of hepatocyte proliferation after partial hepa-
tectomy (pH) in Keap1+/+ and Keap1+/− mice. (A) Liver cryosections prepared from 3 mice per 
time point per genotype were stained with dihydroethidium (DHe). the DHe was oxidized by 
hepatic free radicals, which generated 2-hydroxyethidium and ethidium. ethidium-stained DNA 
exhibited red fluorescence. Representative photographs of liver sections (400×) were taken using 
the same contrast and lightness parameters and are shown. (B) Hepatic malondialdehyde (MDA) 
equivalents were quantified to monitor lipid peroxidation indicative of oxidative stress using a 
thiobarbituric acid reactive substances (tBARS) assay kit. the data are shown as the means of MDA 
equivalents (nmol/mg liver) ± SD (n = 3 mice/time point/genotype). Asterisks represent P < 0.05 in 
comparison between Keap1+/+ and Keap1+/− mice. NL, normal liver.
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times with water, and subjected to qRT-PCR to quantify mRNA 
levels. TaqMan Universal PCR Master Mix and the primers 
and TaqMan MGB probes of mouse Nrf2 (Mm00477786_
m1), NQO1 (Mm01253561_m1), GPX2 (Mm00850074_g1), 
GSTmu3 (Mm00833923_m1), Klf9 (Mm00495172_m1), 
RAD51 (Mm00487905_m1), RAD51l1 (Mm01302591_m1), 
and albumin (Mm00802090_m1) were purchased from Applied 
Biosystems. The amplification reactions were performed with the 
ABI Prism 7900 sequence detection system (Applied Biosystems) 
with initial hold steps (50 °C for 2 min followed by 95 °C for 10 
min) and 40 cycles of a 2-step PCR (92 °C for 15 s and 60 °C for 
1 min). The comparative CT method was used for the 
relative quantification of the amount of mRNA in each 
sample normalized to the albumin transcript levels.
Hepatic redox assays
Hepatic superoxide was detected and visualized as 
described by Zhang et al.45 Liver cryosections (8 μM) 
were stained with 30 μM dihydroethidium (DHE) 
for 30 min at 37 °C, followed by rinsing with PBS 3 
times. The DHE was oxidized by hepatic free radi-
cals, thus generating 2-hydroxyethidium and ethid-
ium. The red fluorescence elicited by ethidium-stained 
DNA was visualized using a fluorescence microscope. 
Photographs of liver sections (400×) were taken using 
the same contrast and lightness parameters for all the 
samples. In addition, hepatic thiobarbituric acid reactive 
substances (TBARS) were quantified using a TBARS 
assay kit (ZeptoMetrix Corporation) according to the 
manufacturer’s instructions. The TBARS measurement 
was used to monitor lipid peroxidation, a major indi-
cator of oxidative stress. In brief, 50 mg of liver tissue 
per mouse was homogenized in 300 μl of ice-cold PBS. 
Sixty microliters of each liver homogenate was added to 
each reaction. The absorbance of the liver homogenate 
was measured at 532 nm after incubation at 95 °C for 
60 min. TBARS were quantified as malondialdehyde 
(MDA) equivalents using a MDA standard curve.
DNA damage measurements
Immunohistochemistry was performed using an antibody 
against phosphorylated histone H2A.X (γ-H2AX) (S139) (#05–
636, Millipore) with formalin-fixed and paraffin-embedded liver 
sections. DyLight 488-conjugated AffiniPure Goat Anti-Mouse 
IgG (#115–485–174, Jackson ImmunoResearch Laboratories) 
was used as a secondary antibody. The nuclei with more than 4 
γ-H2AX-positive foci were counted in 5 randomly chosen micro-
scope fields (200×) per section.
Figure 6. DNA damage assessments and DNA damage repair 
gene expression during the first wave of hepatocyte prolifera-
tion after partial hepatectomy (pH) in Keap1+/+ and Keap1+/− 
mice. (A) Immunohistochemistry was performed using the 
γ-H2A.X antibody with liver sections prepared from regen-
erating livers at the indicated time points after pH. DyLight 
488-conjugated Affinipure Goat Anti-Mouse IgG was used 
as a secondary antibody. γ-H2A.X+ foci in hepatocyte nuclei 
exhibit green fluorescence. Representative nuclei with 4 or 
more γ-H2A.X+ foci are indicated by arrows. (B) the nuclei with 
more than 4 γ-H2A.X+ foci were counted in 5 randomly cho-
sen microscope fields (200x) per section. the data are shown 
as the means per field ± SD (n = 3 mice/time point/genotype). 
Asterisks represent P < 0.05 in comparison between Keap1+/+ 
and Keap1+/− mice. (C) total RNA was prepared from liver tis-
sues collected prior to or after pH at the indicated time points. 
Hepatic mRNA levels of RAD51 and RAD51l1 were quantified 
by qRt-pCR and are expressed as the mean fold changes com-
pared with wild-type normal controls ± SD (n = 3 mice per 
time point per genotype). Asterisks represent P < 0.05 in com-
parison between Keap1+/+ and Keap1+/− mice.
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Statistical analysis
The data are shown as the means ± standard deviation 
(SD). Statistical analysis was performed using a one-
way analysis of variance or Student t test. Significant 
differences were defined when P < 0.05.
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Figure  7. A hypothesis for Keap1-mediated hepatic redox 
cycle and hepatocyte cell cycle in regenerating livers. Redox 
sensor Keap1 modulates the cycle of free radicals produced 
by regenerating livers by both Nrf2-depedent and -inde-
pendent mechanisms. Keap1 also regulates the activities of 
hepatocyte mitogenic signaling molecules, including c-Met, 
eGFR, Akt1, and p70S6K, and their downstream effectors, 
including Cyclins A2 and B1. Nrf2 needs to be kept quiescent 
when hepatocytes are replicating. the threshold of Keap1 
expression is tightly controlled to ensure the proper coupling 
of hepatic redox cycle and hepatocyte cell cycle, thereby 
enabling hepatocytes to enter and progress through the cell 
cycle smoothly and rhythmically during liver regeneration.
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